VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $10,640,000 | +57.0% | 457,052 | +7.2% | 0.07% | +50.0% |
Q1 2018 | $6,777,000 | +160.0% | 426,335 | +242.3% | 0.04% | +175.0% |
Q4 2017 | $2,607,000 | +51.1% | 124,559 | +3.2% | 0.02% | +45.5% |
Q3 2017 | $1,725,000 | -20.6% | 120,722 | -3.5% | 0.01% | -26.7% |
Q2 2017 | $2,172,000 | +64.3% | 125,107 | +4.4% | 0.02% | +66.7% |
Q1 2017 | $1,322,000 | -81.2% | 119,852 | -75.3% | 0.01% | -82.4% |
Q4 2016 | $7,027,000 | -41.6% | 484,618 | -1.1% | 0.05% | -42.7% |
Q3 2016 | $12,024,000 | +93.4% | 489,967 | +57.9% | 0.09% | +89.4% |
Q2 2016 | $6,216,000 | -30.2% | 310,398 | -8.5% | 0.05% | -29.9% |
Q1 2016 | $8,909,000 | -87.2% | 339,392 | -50.7% | 0.07% | -88.3% |
Q4 2015 | $69,857,000 | -54.3% | 687,832 | -19.9% | 0.58% | -52.9% |
Q3 2015 | $152,710,000 | -21.2% | 858,688 | -1.6% | 1.22% | -9.4% |
Q2 2015 | $193,793,000 | +13.2% | 872,479 | +0.5% | 1.35% | +10.9% |
Q1 2015 | $171,238,000 | +39.0% | 867,995 | +1.0% | 1.22% | +47.8% |
Q4 2014 | $123,197,000 | +3.4% | 859,264 | -5.6% | 0.82% | +15.6% |
Q3 2014 | $119,168,000 | +5.9% | 910,141 | +2.2% | 0.71% | +11.4% |
Q2 2014 | $112,524,000 | +7.8% | 890,254 | +12.2% | 0.64% | +3.6% |
Q1 2014 | $104,411,000 | +35.2% | 793,489 | +20.3% | 0.62% | +30.2% |
Q4 2013 | $77,254,000 | +11.7% | 659,340 | -0.5% | 0.47% | +7.0% |
Q3 2013 | $69,183,000 | +27.2% | 662,523 | +5.1% | 0.44% | +19.1% |
Q2 2013 | $54,377,000 | – | 630,366 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |